previous experiments from this laboratory demonstrated that oral administration of d-penicillamine ( dpa ) throughout gestation produced significant teratogenic effects and low copper concentrations in both maternal and fetal tissues in a dose-related manner .
C0030817
d-penicillamine
C0032961
gestation